Shine-On BioMedical ,Ltd. Profit Margin

Shine-On BioMedical ,Ltd. (6926.TWO) currently reports a profit margin of -590.29% as of June 2026. That compares with -1029.28% in the prior-year period — up 42.7% year over year. That is below the Healthcare sector average of 9.48%. Use the charts on this page to explore Shine-On BioMedical ,Ltd.'s profit margin history and peer comparisons.

Shine-On BioMedical ,Ltd.'s profit margin increased from -1029.28% to -590.29% — a 42.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Shine-On BioMedical ,Ltd.'s profit margin of -590.29% is lower than the Healthcare sector average of 9.48%. That is roughly 6326.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Shine-On BioMedical ,Ltd.'s current -590.29% should be judged against Healthcare norms (sector average: 9.48%) and against 6926.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -590.29%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.48%. From there, open related valuation or income-statement pages for Shine-On BioMedical ,Ltd., and consider following 6926.TWO for alerts when major investors trade the stock.